StemCore Laboratories: Catalyzing genomics projects in the Nation’s Capital

October 4, 2018

StemCore Laboratories is one of Canada’s most advanced genomics facilities, fueling breakthroughs in stem cell research and regenerative medicine, as well as other health-related areas such as cancer, heart disease, and diabetes. Located at the General Campus of the Ottawa Hospital, StemCore is a core facility of the Ottawa Hospital Research Institute (OHRI) and the…

Read More

Ontario Agriculture & Agri-food Sector to benefit from Regional Priorities Partnership Program

October 4, 2018

October 3, 2018, Ontario, Canada – Putting genomics innovations in the hands of those who use them leads to increased competitiveness, economic growth and job creation. Today, Ontario Genomics (OG), The Agricultural Adaptation Council (AAC) and Genome Canada (GC) announced the launch of the Ontario Regional Priorities Partnership program (ON-RP3) – a new, industry-pull funding…

Read More

Job Opportunity – OG Project Coordinator (Oct 26, 2018)

September 28, 2018

Administers processes for tracking, submission and monitoring of project details and supports the Research Operations and Project Management Office to ensure data is accurate and relevant. Provides administrative support to the Sector Research Program Management team as required for pre-award and/or post-award activities as assigned.

Read More

Job Opportunity – OG Director of Communications (Oct 26, 2018)

August 28, 2018

The Director of Communications is responsible for creating, implementing and evaluating communication strategies to shape, serve and brand the organization’s mission to be a leader and catalyst in advancing the application of genomics technologies in Ontario’s key economic sectors, raising the visibility of Ontario Genomics as an important player in the provincial economy, and enhancing its image among key constituents.

Read More

New applied genomics projects to spur innovative technologies and job creation in agri-food, health and the environment

August 16, 2018

August 16, 2018, Lincoln, Ontario – The application of genomics-based research and development is strengthening Ontario’s economy. It is leading to much needed advancements in farming practices, health care, and environmental stewardship. Bringing together academic researchers with companies to accelerate technology development lays the foundation for increased competitiveness, economic growth and job creation. Today, the…

Read More

Cracking the code

August 7, 2018

As published on the July/August 2018 Water Canada Magazine By Britney Hess Ontario unlocks genomic information to propel the circular economy. Understanding the genomics of our biological planet is key to addressing the grand challenges facing our world today, from climate change and global population growth to increasing food and energy demands, health issues, and protection of our natural resources. Every…

Read More

Gene editing tool CRISPR back in the bad books?

July 25, 2018

Recently a research paper in the prestigious journal Nature was retracted; it had raised concerns that the CRISPR-based gene editing technique may cause widespread genetic damage but the authors faced criticism over the use of experimental controls. A new paper just release has raised new doubts, at least about the use of CRISPR to do gene editing inside people’s bodies. The new research found large deletions in about a fifth of the CRISPR-exposed cells. This problem may be circumvented by newer variations in the CRISPR technique, but caution appears warranted in proceeding to therapeutic use.

Read More

The UK’s NHS to offer routine DNA tests

July 24, 2018

People in England will soon have access to DNA tests on an unprecedented scale when their health service becomes the first in the world to routinely offer genomic medicine. The service will first focus on cancers and rare diseases, with future tests to identify patients who may react badly to certain drugs, as well as tests that may predict onset of a disease such as Parkinson’s, multiple sclerosis and dementia. This initiative is an outcome of the UK’s 100,000 Genomes project and benefits from the expertise developed therein.

Read More